Novel Insight into Neurofilament Light Chain and Rhythm Outcomes after Catheter Ablation of New Onset Atrial Fibrillation:A Prospective Cohort Study

Fuding Guo,Jun Wang,Min Wu,Seng Yang,Chende He,Mei Lu,Xiaohua Zhao,Hong Jiang,Qiwei Liao,Shaolong Li
DOI: https://doi.org/10.1016/j.hrthm.2024.08.048
IF: 6.779
2024-01-01
Heart Rhythm
Abstract:Background Atrial fibrillation (AF) is an age-related disorder closely linked to autonomic nervous system dysfunction. Neurofilament light chain (NFL) protein is a biomarker for neurodegenerative diseases. Objective This study aims to evaluate the predictive value of NFL in forecasting AF recurrence following ablation. Methods We included patients initially diagnosed with AF who underwent catheter ablation. Serum NFL levels were measured using an enzyme-linked immunosorbent assay. The primary outcome was AF recurrence during follow-up. Results A total of 215 consecutive patients were enrolled, with an average follow-up period of 10.69 months. During this period, 29 patients experienced AF recurrence. Multivariate Cox regression analysis revealed that high NFL levels (≥300 pg/ml) were an independent predictor of recurrence risk (adjusted hazard ratio [HR]: 3.756; 95% confidence interval [CI]: 1.392 to 10.136). The associations between NFL levels and AF recurrence were consistent across subgroups defined by age (>65 years), gender, hypertension, and paroxysmal AF. Restricted cubic spline analysis showed a consistent linear relationship across the entire range of NFL levels. Furthermore, incorporating NFL into the CHA2DS2-VASc score model significantly improved the prediction of recurrent AF risk, as demonstrated by time-dependent area under the curve and decision curve analysis. Notable enhancements were also observed in terms of net reclassification improvement (0.464, 95% CI: 0.226–0.675, P<0.05) and integrated discrimination improvement (0.087, 95% CI: 0.017–0.183, P=0.08). Conclusions NFL may serve as an effective biomarker for risk stratification and therapeutic decision-making in patients with new onset AF who have undergone catheter ablation.
What problem does this paper attempt to address?